Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
1.
J. appl. oral sci ; 27: e20180641, 2019. tab, graf
Article Dans Anglais | LILACS, BBO | ID: biblio-1012519

Résumé

Abstract Objectives: Infection, inflammation and bone resorption are closely related events in apical periodontitis development. Therefore, we sought to investigate the role of cyclooxygenase (COX) in osteoclastogenesis and bone metabolism signaling in periapical bone tissue after bacterial lipopolysaccharide (LPS) inoculation into root canals. Methodology: Seventy two C57BL/6 mice had the root canals of the first molars inoculated with a solution containing LPS from E. coli (1.0 mg/mL) and received selective (celecoxib) or non-selective (indomethacin) COX-2 inhibitor. After 7, 14, 21 and 28 days the animals were euthanized and the tissues removed for total RNA extraction. Evaluation of gene expression was performed by qRT-PCR. Statistical analysis was performed using analysis of variance (ANOVA) followed by post-tests (α=0.05). Results: LPS induced expression of mRNA for COX-2 (Ptgs2) and PGE2 receptors (Ptger1, Ptger3 and Ptger4), indicating that cyclooxygenase is involved in periapical response to LPS. A signaling that favours bone resorption was observed because Tnfsf11 (RANKL), Vegfa, Ctsk, Mmp9, Cd36, Icam, Vcam1, Nfkb1 and Sox9 were upregulated in response to LPS. Indomethacin and celecoxib differentially modulated expression of osteoclastogenic and other bone metabolism genes: celecoxib downregulated Igf1r, Ctsk, Mmp9, Cd36, Icam1, Nfkb1, Smad3, Sox9, Csf3, Vcam1 and Itga3 whereas indomethacin inhibited Tgfbr1, Igf1r, Ctsk, Mmp9, Sox9, Cd36 and Icam1. Conclusions: We demonstrated that gene expression for COX-2 and PGE2 receptors was upregulated after LPS inoculation into the root canals. Additionally, early administration of indomethacin and celecoxib (NSAIDs) inhibited osteoclastogenic signaling. The relevance of the cyclooxygenase pathway in apical periodontitis was shown by a wide modulation in the expression of genes involved in both bone catabolism and anabolism.


Sujets)
Animaux , Mâle , Ostéogenèse/physiologie , Tissu périapical/effets des médicaments et des substances chimiques , Tissu périapical/métabolisme , Lipopolysaccharides/pharmacologie , Inhibiteurs des cyclooxygénases/pharmacologie , Prostaglandin-endoperoxide synthases/physiologie , Cavité pulpaire de la dent/métabolisme , Ostéogenèse/effets des médicaments et des substances chimiques , Facteurs temps , Résorption osseuse/métabolisme , Expression des gènes , Régulation positive , Anti-inflammatoires non stéroïdiens/pharmacologie , Indométacine/pharmacologie , Lipopolysaccharides/analyse , Prostaglandin-endoperoxide synthases/analyse , Prostaglandin-endoperoxide synthases/effets des médicaments et des substances chimiques , Récepteur prostaglandine E/analyse , RT-PCR , Escherichia coli/métabolisme , Cyclooxygenase 2/analyse , Célécoxib/pharmacologie , Souris de lignée C57BL
2.
Braz. j. med. biol. res ; 32(11): 1345-52, Nov. 1999.
Article Dans Anglais | LILACS | ID: lil-248428

Résumé

Cardiac surgery involving ischemic arrest and extracorporeal circulation is often associated with alterations in vascular reactivity and permeability due to changes in the expression and activity of isoforms of nitric oxide synthase and cyclooxygenase. These inflammatory changes may manifest as systemic hypotension, coronary spasm or contraction, myocardial failure, and dysfunction of the lungs, gut, brain and other organs. In addition, endothelial dysfunction may increase the occurrence of late cardiac events such as graft thrombosis and myocardial infarction. These vascular changes may lead to increased mortality and morbidity and markedly lengthen the time of hospitalization and cost of cardiac surgery. Developing a better understanding of the vascular changes operating through nitric oxide synthase and cyclooxygenase may improve the care and help decrease the cost of cardiovascular operations.


Sujets)
Pontage cardiopulmonaire , Vaisseaux coronaires/physiopathologie , Arrêt cardiaque provoqué , Ischémie myocardique , Nitric oxide synthase/physiologie , Prostaglandin-endoperoxide synthases/physiologie , Perméabilité capillaire , Endothélium/anatomopathologie , Muscles lisses
4.
Rev. chil. neuro-psiquiatr ; 26(2): 142-52, abr.-jun. 1988. ilus
Article Dans Espagnol | LILACS | ID: lil-56359

Résumé

Los eicosanoides son derivados de ácidos grasos esenciales poliinsaturados de 20 átomos de carbono que afectan prácticamente todas las funciones biológicas. Se ha propuesto un rol modulador a nivel del sistema nervioso central para ellos. La presente revisión se refiere al posible rol central de los eicosanoides, productos de dos vías biosintéticas: la ciclooxigenasas y las lipooxigenasas, así como el rol de agentes terapéuticos que actúan sobre ellos. Se analiza su efecto sobre la circulación cerebrovascular y su acción neuromoduladora, que afecta la función hipotalámica, el umbral convulsivante y la nocicepción, entre ellos. Claramente durante los últimos años el descubrimiento del tromboxano, prostaciclina y leucotrienos ha desviado el interés de las prostaglandinas primarias (PGE y PGF) en busca de acciones fisiológicas mas específicas


Sujets)
Humains , Acides arachidoniques/biosynthèse , Acides éicosanoïques/métabolisme , Circulation cérébrovasculaire , Prostaglandin-endoperoxide synthases/physiologie , Cerveau/métabolisme , Antienzymes , Prostacycline , Leucotriène B4 , Thromboxanes
SÉLECTION CITATIONS
Détails de la recherche